:CAR-T

Zhibo Zheng1, Siyuan Li2, Mohan Liu3

  • 1Department of International Medical Services, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.

Cancers
|July 14, 2023
PubMed
概括

化学抗原受体 (CAR) -T细胞疗法通过基因修饰T细胞以向癌症来增强免疫疗法. 最近的进展旨在克服诸如毒性和固体瘤透等局限性,以实现更广泛的应用.